Loading...
Patients gain a lot of weight with atypical antipsychotics; one recent study found an average gain of more than 37 pounds with olanzapine (Journal Watch Psychiatry Aug 27 2007). Few placebo-controlled studies have been conducted into possibly helpful medications. Because some patients taking atypicals develop the metabolic syndrome, which includes problems of glycemic control, metformin has been proposed as a potential treatment; however, results have been inconsistent (for a pediatric study, see Journal Watch Psychiatry Jan 12 2007). Recently, investigators in Venezuela performed a 12-week, randomized, placebo-controlled trial in 80 patients (60 inpatients, 76 diagnosed with schizophrenia) who had been receiving treatment with olanzapine f…